Blood

Theranos’ Holmes is criminally convicted, a rare fate for a tech exec, while biotech heats up

Snacks / Tuesday, January 04, 2022

Get the jury some takeout... After a whopping 50 hours of deliberations, jurors found Theranos founder Elizabeth Holmes guilty on 4 of 11 charges in her criminal trial. The 37-year-old was convicted of three fraud counts against investors in her disgraced blood-testing startup, and one count of conspiracy to commit fraud.

  • Investor-focused verdict: Holmes was acquitted on four separate counts that alleged she defrauded patients who paid for Theranos' misleading tests.
  • Holmes faces up to 20 years in prison for each count when sentenced, though it's unlikely she'll get the max sentence of 80 years. Still, it’s unusual for a Silicon Valley exec to actually go to prison.

Bad blood money... Theranos claimed that with just a few finger pricks of blood its tests could detect health conditions from cancer to high cholesterol. Holmes raised $900M+ from investors, growing the company to a $9B valuation and becoming the youngest female self-made billionaire on paper. Holmes was convicted for lying to investors about the accuracy of Theranos' machines. And still…

  • Biotech funding = undented. Despite the cautionary tale, funding for private US biotech companies has nearly 3X'd since 2015 to $27.2B (and boomed since Covid).
  • The regulatory gap that allowed Theranos to sell its tests hasn’t been closed, and other companies have used it to roll out unapproved diagnostic tests to patients.

Industry investors are mostly unfazed... Theranos doesn’t seem to have dramatically changed how investors select companies to fund, or how openly startups share information. Notably, Theranos’ funding wasn’t typical of the traditional Silicon Valley model — it was largely backed by prominent individuals (like Walmart's Walton family and Rupert Murdoch). Also notable: Theranos’ board was light on medical experts, while including distinguished former national-security leaders (James Mattis, Henry Kissinger). Still, the Theranos saga shows the importance of rigor and transparency when it comes to due diligence.

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.